Congressional Hearings

Senate

Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• June 22, 2017 – Hearing to Review the FY2018 Budget Request for the National Institutes of Health

House

Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

• May 23, 2017 – U.S. Public Health Response to the Zika Virus: Continuing Challenges

Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 17, 2017 – Oversight Hearing - Advances in Biomedical Research

Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

• March 21, 2017 – Fentanyl: The Next Wave of the Opioid Crisis

Session I

Senate

Committee on Appropriations – Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 30, 2015 – FY 2016 Budget Request for NIH
  • Written Statement for Francis Collins, Director, NIH
• October 7, 2015 – The NIH: Investing in a Healthier Future
  • Written Statement for Francis Collins, Director, NIH

Committee on Health, Education Labor and Pensions

• March 10, 2015 – US Medical Innovation
  • Written Statement for Francis Collins, Director, NIH

• April 28, 2015 – Medical Innovation for Patients
  • Written Statement for Christopher Austin, Director, NCATS
  • Written Statement for Roderic Pettigrew, Director, NIBIB
• May 5, 2015 – Precision Medicine
  • Written Statement for Francis Collins, Director, NIH

• October 29, 2015 – Mental Health Issues
  • Written Statement for Thomas Insel, Director, NIMH

Committee on Special Aging

• March 25, 2015 – Alzheimer’s Disease
  • Written Statement for Richard Hodes, Director, NIA

House

Committee on Appropriations, Subcommittee on Labor Health and Human Services, Education, and Related Agencies

• March 3, 2015 – FY 2016 Budget Request for NIH
  • Written Statement for Francis Collins, Director, NIH

• April 15, 2015 – Ebola
  • Written Statement for Anthony Fauci, Director, NIAID

Committee on Energy and Commerce, Subcommittee on Health

• April 30, 2015 – 21st Century Cures Bill
  • Written Statement for Kathy Hudson, Deputy Director for Science, Outreach, and Policy

Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

• February 3, 2015 – The U.S. Public Health Response to Seasonal Influenza
  • Written Statement for Anthony Fauci, Director, NIAID

• May 1, 2015 – Opioid Abuse
  • Written Statement for Nora Volkow, Director, NIDA
• November 19, 2015 – Flu Preparedness
  • Written Statement for Carole Heilman, Director, Division of Microbiology and Infectious Diseases, NIAID

SESSION II

Senate

Senate Committee on Appropriations – Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 7, 2016 – Fiscal Year 2017 Budget Request
  • Written Statement for Francis Collins, Director, NIH

Senate Committee on Health, Education, Labor, and Pensions Committee

• February 24, 2016 – Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

Senate Committee on Labor, Health and Human Services, Education, and Related Agencies

• February 11, 2016 – Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Emerging and Re-emerging Infectious Diseases Including Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

House

House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

• March 2, 2016 – Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

• April 20, 2016 – Laboratory Safety at NIH
  • Written Statement for Lawrence Tabak, Deputy Director, NIH

• June 14, 2016 – The Role of the National Institute of Allergy and Infectious Diseases Research in Combating Antibiotic Resistance
  • Written Statement for Dennis Dixon, Chief, Bacteriology and Mycology Branch, NIAID

• September 27, 2016 – Lab Safety and Inactivation of Microbiological Agents at NIH
  • Written Statement for Jeffrey Potts, Biorisk Manager, NIH

House Committee on Foreign Affairs, Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations and Subcommittee on the western Hemisphere

• February 10, 2016 – Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

House Committee on Labor, Health and Human Services, Education, and Related Agencies

• March 16, 2016 – Fiscal Year 2017 Budget Request
  • Written Statement for Francis Collins, Director, NIH

House Committee on Oversight and Government Reform

• February 24, 2016 – Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

House Committee on Science, Space, and Technology, Subcommittee on Research & Technology

• June 16, 2016 – SBIR/STTR Reauthorization: A Review of Technology Transfer
  • Written Statement for Michael Lauer, Deputy Director for Extramural Research

House Committee on Small Business

• March 2, 2016 – Commercializing on Innovation: Reauthorizing the Small Business Innovation Research and Small Business Technology Transfer Program
  • Written Statement for Matthew Portnoy, Director, Division of Special Programs

House Democratic Steering and Policy Committee

• May 12, 2016 – Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

Session I

Senate

Committee on Appropriations-Subcommittee on Labor, HHS, and Education

• May 15, 2013 – Fiscal Year 2014 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, NIH Director
  • Written Statement for Dr. Anthony Fauci, NIAID Director
  • Written Statement for Dr. Gary Gibbons, NHLBI Director
  • Written Statement for Dr. Richard Hodes, NIA Director
  • Written Statement for Dr. Story Landis, NINDS Director
  • Written Statement for Dr. Harold Varmus, NCI Director

Committee on Health, Education, Labor, and Pensions

• January 24, 2013 – Assessing the State of America’s Mental Health System
  • Written Statement for Dr. Thomas Insel, NIMH Director

House of Representatives

Committee on Appropriations-Subcommittee on Labor, HHS, and Education

• March 5, 2013 – Fiscal Year 2014 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, NIH Director

Session II

Senate

Committee on Appropriations

• April 29, 2014 – Federal Investments in Innovation
  • Written Statement for Dr. Francis Collins, NIH Director

Committee on Appropriations – Subcommittee on Labor, HHS, and Education

• September 16, 2014 – The Ebola Threat in West Africa
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

• April 2, 2014 – Fiscal Year 205 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, Director, NIH
• February 27, 2014 – PHEMCE
  • Written Statement for Dr. Michael Kurilla, Associate Director for Biodefense Product Development, NIAID
• February 26, 2014 – Alzheimer’s Disease
  • Written Statement for Dr. Francis Collins, Director, NIH

Committee on Special Aging

• June 25, 2014 – Brain Injuries and Diseases of Aging
  • Written Statement for Dr. Walter Koroshetz, Deputy Director, NINDS

• May 7, 2014 – Cancer Challenges
  • Written Statement for Dr. Harold Varmus, Director, NCI

Committee on Veteran’s Affairs

• April 30, 2014 – Veterans and Overmedication
  • Written Statement for Dr. Josephine Briggs, Director, NCCAM

Caucus on International narcotics Control

• May 14, 2014 – America’s Addiction to Opioids: Heroin and Prescription Drug Abuse
  • Written Statement for Dr. Nora Volkow, Director, NIDA

House

Committee on Appropriations – Subcommittee on Labor, HHS, and Education

• March 26, 2014 – Future of Biomedical Research
  • Written Statement for Dr. Francis Collins, Director, NIH

Committee on Energy and Commerce – Subcommittee on Health

• November 19, 2014 – Medical Product Development After Ebola
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

Committee on Energy and Commerce – Subcommittee on Oversight and Investigation

• October 16, 2014 – Ebola Prevention and Response Efforts
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

• April 29, 2014 – Prescription Drug and Heroin Abuse
  • Written Statement for Dr. Nora Volkow, Director, NIDA

Committee on Foreign Affairs – Subcommittee on Africa, Global Health, Global Human Rights and International Organization

• September 17, 2014 – Global Efforts to Fight Ebola
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

Committee on Science, Space and Technology – Subcommittee on Research and Technology

• July 17, 2014 – Innovative Medical Achievements
  • Written Statement for Dr. Harold Varmus, Director, NCI

Committee on Small Business

• July 23, 2014 – Small Business Innovation Research and Small Business Technology Transfer Programs
  • Written Statement for Matthew Portnoy, Director, Division of Special Programs, Manager, National Institutes of Health SBIR/STTR Program

Committee on Oversight and Government Reform – Subcommittee on Government Operations

• June 20, 2014 – The Adverse Health Effects of Marijuana Use
  • Written Statement for Dr. Nora Volkow, Director, NIDA

• May 20, 2014 – The Federal Government’s Response to autism
  • Written Statement for Dr. Thomas Insel, Director, NIMH

• May 14, 2014 – America’s Addiction to Opioids: Heroin and Prescription Drug Abuse
  • Written Statement for Dr. Nora Volkow, Director, NIDA

Session I

Senate

Committee on Appropriations-Subcommittee on Labor, HHS, and Education

• May 11, 2011 – Fiscal Year 2012 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, NIH Director

Committee on Environmental and Public Works

• February 2, 2011 – Drinking Water Contaminants
  • Written Statement for Dr. Linda Birnbaum, NIEHS Director

Committee on Homeland Security and Government Affairs

• June 22, 2011 – Transforming Lives Through Diabetes Research
  • Written Statement for Dr. Griffin Rodgers, NIDDK Director

House of Representatives

Committee on Energy and Commerce-Subcommittee on Health

• July 11, 2011 – Legislative Hearing on Various Bills (including the Combating Autism Reauthorization Act)
  • Written Statement for Dr. Thomas Insel, NIMH Director

Committee on Foreign Affairs-Subcommittee on Africa, Global Health, and Human Rights

• June 23, 2011 – Global Strategies to Combat Alzheimer’s Disease
  • Written Statement for Dr. Richard Hodes, NIA Director

Committee on Science, Space, and Technology-Subcommittee on Technology and Innovation

• March 31, 2011 – The Role of Small Business in Innovation and Job Creation: The SBIR/STTR Programs
  • Written Statement for Dr. Sally Rockey, NIH Deputy Director for Extramural Research

Session II

Senate

Committee on Appropriations-Subcommittee on Labor, HHS, and Education

• March 28, 2012 – Fiscal Year 2013 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, NIH Director
  • Written Statement for Dr. Anthony Fauci, NIAID Director
  • Written Statement for Dr. Richard Hodes, NIA Director
  • Written Statement for Dr. Thomas Insel, NIMH Director (testified as the Acting NCATS Director)
  • Written Statement for Dr. Griffin Rodgers, NIDDK Director
  • Written Statement for Dr. Harold Varmus, NCI Director

Committee on Environmental and Public Works-Subcommittee on Water and Wildlife

• April 24, 2012 – Legislative Hearing on Various Bills (including the Great Apes Protection and Cost Savings Act of 2011)
  • Written Statement for Dr. James Anderson, NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives

Committee on Health, Education, Labor, and Pensions

• February 14, 2012 – Pain in America: Exploring Challenges to Relief
  • Written Statement for Dr. Lawrence Tabak, NIH Principal Deputy Director

Committee on Homeland Security and Government Affairs

• April 26, 2012 – Biological Security: The Risk of Dual-Use Research
  • Written Statement for Dr. Anthony Fauci, NIAID Director

House of Representatives

Committee on Appropriations-Subcommittee on Labor, HHS, and Education

• March 20, 2012 – Fiscal Year 2013 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, NIH Director
  • Written Statement for Dr. Thomas Insel, NIMH Director (testified as the Acting NCATS Director)

Committee on Energy and Commerce-Subcommittee on Health

• June 21, 2012 – NIH: A Review of Its Reforms, Priorities, and Progress
  • Written Statement for Dr. Francis Collins, NIH Director

Committee on Oversight and Government Reform

• December 12, 2012 – HGH Testing in the NFL: Is the Science Ready?
  • Written Statement for Dr. Lawrence Tabak, NIH Principal Deputy Director
• November 29, 2012 – 1 in 88 Children: A Look into the Federal Response to Rising Rates of Autism
  • Written Statement for Dr. Alan Guttmacher, NICHD Director

Committee on Science, Space, and Technology-Subcommittee on Investigations and Oversight and the Committee on Small Business-Subcommittee on Healthcare and Technology (joint hearing)

• April 25, 2012 – How the Report on Carcinogens Uses Science to Meet Its Statutory Obligations, and Its Impact on Small Business Jobs
  • Written Statement for Dr. Linda Birnbaum, NIEHS Director